CPHI vs JD · rev $4.1M vs P/E 7.6, rev $187.20B
China Pharma Holdings Inc (CPHI) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
CPHI currently screens at market cap $29.0M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the CPHI and JD stock pages for the full models.
Not investment advice.